Author provides a bullish LULU thesis centered on Ozempic-driven leggings demand and Asian expansion, expressed via March 2027 call options.
LULU — LONG The author argues LULU is misclassified as consumer discretionary and is really a consumer staple benefiting from body-image spending; the 'firming and sculpting' leggings category targets the 30-55, higher-income Ozempic demographic, which drives repeat purchases after weight loss. Catalysts cited include tariffs being 'practically gone,' war ending eventually and no Fed rate hikes, plus heavy expansion in China and South Korea where LULU is a status symbol and Ozempic search interest correlates with the brand. Main stated risks are tariffs, war/rate-hike fears, and lack of innovation, all of which the author dismisses. The author expresses this with 5x MAR27 LEAPS 130C on LULU; LULU is the underlying proxy.
I rest my case.
5x MAR27 LEAPS 130C
This Reddit post, published June 04, 2026, features u/Sensitive-Radish-292 discussing LULU. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/Sensitive-Radish-292 · Tickers: LULU